Abbott Laboratories (ABT) has filed a Form 144, indicating a planned sale of 5,850 common shares. The sale is related to vested awards and will be executed through UBS Financial Services.
Abbott Laboratories Files for NYSE Stock Sale of Vested Awards
|1 min read
Abbott LaboratoriesStock SaleCorporate ActionNYSEHealthcare
